Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys

Abstract

Host cell barriers to the early phase of immunodeficiency virus replication explain the current distribution of these viruses among human and non-human primate species1,2,3,4. Human immunodeficiency virus type 1 (HIV-1), the cause of acquired immunodeficiency syndrome (AIDS) in humans, efficiently enters the cells of Old World monkeys but encounters a block before reverse transcription2,3,4. This species-specific restriction acts on the incoming HIV-1 capsid5,6,7 and is mediated by a dominant repressive factor7,8,9. Here we identify TRIM5α, a component of cytoplasmic bodies, as the blocking factor. HIV-1 infection is restricted more efficiently by rhesus monkey TRIM5α than by human TRIM5α. The simian immunodeficiency virus, which naturally infects Old World monkeys10, is less susceptible to the TRIM5α-mediated block than is HIV-1, and this difference in susceptibility is due to the viral capsid. The early block to HIV-1 infection in monkey cells is relieved by interference with TRIM5α expression. Our studies identify TRIM5α as a species-specific mediator of innate cellular resistance to HIV-1 and reveal host cell components that modulate the uncoating of a retroviral capsid.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Rhesus monkey TRIM5αrh preferentially blocks HIV-1 infection.
Figure 2: TRIM5αrh blocks HIV-1 infection before or during early reverse transcription.
Figure 3: HIV-1 infection is blocked less efficiently by TRIM5 variants than by TRIM5αrh.
Figure 4: TRIM5αrh is essential for the block to HIV-1 infection in PRL cells.

Similar content being viewed by others

References

  1. LaBonte, J., Babcock, G., Patel, T. & Sodroski, J. Blockade of human immunodeficiency virus (HIV-1) of New World monkey cells occurs primarily at the stage of virus entry. J. Exp. Med. 196, 431–435 (2002)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Shibata, R., Sakai, H., Kawamura, M., Tokunaga, K. & Adachi, A. Early replication block of human immunodeficiency virus type 1 in monkey cells. J. Gen. Virol. 76, 2723–2730 (1995)

    Article  CAS  PubMed  Google Scholar 

  3. Himathongkham, S. & Luciw, P. A. Restriction of HIV-1 (subtype B) replication at the entry step in rhesus macaque cells. Virology 219, 485–488 (1996)

    Article  CAS  PubMed  Google Scholar 

  4. Hofmann, W. et al. Species-specific, postentry barriers to primate immunodeficiency virus infection. J. Virol. 73, 10020–10028 (1999)

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Owens, C. M., Yang, P. C., Gőttlinger, H. & Sodroski, J. Human and simian immunodeficiency virus capsid proteins are major viral determinants of early, post-entry replication blocks in simian cells. J. Virol. 77, 726–731 (2003)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Kootstra, N. A., Munk, C., Tonnu, N., Landau, N. R. & Verma, I. M. Abrogation of postentry restriction of HIV-1 based lentiviral vector transduction in simian cells. Proc. Natl Acad. Sci. USA 100, 1298–1303 (2003)

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  7. Cowan, S. et al. Cellular inhibitors with Fv-1-like activity restrict human and simian immunodeficiency virus tropism. Proc. Natl Acad. Sci. USA 99, 11914–11919 (2002)

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  8. Besnier, C., Takeuchi, Y. & Towers, G. Restriction of lentivirus in monkeys. Proc. Natl Acad. Sci. USA 99, 11920–11925 (2002)

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  9. Munk, C., Brandt, S. M., Lucero, G. & Landau, N. R. A dominant block to HIV-1 replication at reverse transcription in simian cells. Proc. Natl Acad. Sci. USA 99, 13843–13848 (2002)

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  10. Kanki, P. J., Alroy, J. & Essex, M. Isolation of T-lymphotropic retrovirus related to HTLV-III/LAV from wild-caught African green monkeys. Science 230, 951–954 (1985)

    Article  ADS  CAS  PubMed  Google Scholar 

  11. Reddy, B. A., Etkin, L. D. & Freemont, P. S. A novel zinc finger coiled-coil domain in a family of nuclear proteins. Trends Biochem. Sci. 17, 344–345 (1992)

    Article  CAS  PubMed  Google Scholar 

  12. Borden, K. L. RING fingers and B-boxes: zinc-binding protein–protein interaction domains. Biochem. Cell Biol. 76, 351–358 (1998)

    Article  CAS  PubMed  Google Scholar 

  13. Reymond, A. et al. The tripartite motif family identifies cell compartments. EMBO J. 20, 2140–2151 (2001)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Xu, L. et al. BTBD1 and BTBD2 colocalize to cytoplasmic bodies with the RBCC/tripartite motif protein, TRIM5δ. Exp. Cell Res. 288, 84–93 (2003)

    Article  CAS  PubMed  Google Scholar 

  15. Feng, Y., Broder, C. C., Kennedy, P. E. & Berger, E. A. HIV-1 entry co-factor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872–877 (1996)

    Article  ADS  CAS  PubMed  Google Scholar 

  16. Li, J., Lord, C. I., Haseltine, W., Letvin, N. L. & Sodroski, J. Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins. J. AIDS 5, 639–646 (1992)

    CAS  Google Scholar 

  17. Dorfman, T. & Gőttlinger, H. G. The human immunodeficiency virus type 1 capsid p2 domain confers sensitivity to the cyclophilin-binding drug SDZ NIM 811. J. Virol. 70, 5751–5757 (1996)

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Waterman, H., Levkowitz, G., Alroy, I. & Yarden, Y. The RING finger of c-CBL mediates desensitization of the epidermal growth factor receptor. J. Biol. Chem. 274, 22151–22154 (1999)

    Article  CAS  PubMed  Google Scholar 

  19. Owens, C. M. et al. Binding and susceptibility to post-entry restriction factors in monkey cells are specified by distinct regions of the human immunodeficiency virus type 1 capsid. J. Virol. (in the press)

  20. Fassati, A. & Goff, S. P. Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1. J. Virol. 75, 3626–3635 (2001)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Forshey, B. M., von Schwedler, U., Sundquist, W. I. & Aiken, C. Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication. J. Virol. 76, 5667–5677 (2002)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Schwartz, O., Maréchal, V., Friguet, B., Arenzana-Seisdedos, F. & Heard, J.-M. Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1. J. Virol. 72, 3845–3850 (1998)

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Turelli, P. et al. Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: interference with early steps of viral replication. Mol. Cell 7, 1245–1254 (2001)

    Article  CAS  PubMed  Google Scholar 

  24. Marcello, A. et al. Recruitment of human cyclin T1 to nuclear bodies through direct interaction with the PML protein. EMBO J. 22, 2156–2166 (2003)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Bonilla, W. V. et al. Effects of promyelocytic leukemia protein on virus-host balance. J. Virol. 76, 3810–3818 (2002)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Chee, A. V., Lopez, P., Pandolfi, P. P. & Roizman, B. Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects. J. Virol. 77, 7101–7105 (2003)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Rhodes, D. A. et al. The 52,000 MW Ro/SS-A autoantigen in Sjogren's syndrome/systemic lupus erythematosus (Ro52) is an interferon-γ inducible tripartite motif protein associated with membrane proximal structures. Immunology 106, 246–256 (2002)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Toniato, E. et al. TRIM8/GERP RING finger protein interacts with SOCS-1. J. Biol. Chem. 277, 37315–37322 (2002)

    Article  CAS  PubMed  Google Scholar 

  29. Mariani, R. et al. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 114, 21–31 (2003)

    Article  CAS  PubMed  Google Scholar 

  30. Butler, S., Hansen, M. S. T. & Bushman, F. A quantitative assay for HIV DNA integration in vivo. Nature Med. 7, 631–634 (2001)

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank S. Farnum and Y. McLaughlin for manuscript preparation; and S. Basmaciogullari, R. Lu, N. Vandegraaff and A. Engelman for advice and reagents. This work was supported by grants from the NIH, by a Center for AIDS Research Award, by the International AIDS Vaccine Initiative, and by the Bristol-Myers Squibb Foundation. M.S. is supported by a National Defense Science and Engineering Fellowship and is a Fellow of the Ryan Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joseph Sodroski.

Ethics declarations

Competing interests

The authors declare that they have no competing financial interests.

Supplementary information

Supplementary Figure 1

TRIM5αrh restricts infectious HIV-1 replication at an increased multiplicity of infection. (PDF 50 kb)

Supplementary Figure 2

Effects of the HA tag on the ability of human and rhesus TRIM5α to restrict virus infection. (PDF 64 kb)

Supplementary Figure 3

Interference with TRIM5αrh expression in rhesus kidney cells relieves the post-entry restriction to HIV-1. (PDF 79 kb)

Supplementary Figure Legends (DOC 21 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stremlau, M., Owens, C., Perron, M. et al. The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys. Nature 427, 848–853 (2004). https://doi.org/10.1038/nature02343

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nature02343

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing